机译:甲状腺髓样癌患者组织与血清降钙素和癌胚抗原的差异
Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, 800 Rose Street, Room MS 147, Lexington, KY, 40536, USA;
Thyroid Cancer Research Laboratory, Veterans Affairs Medical Center, Lexington, KY, USA;
Department of General Surgery, University of Kentucky Medical Center, Lexington, KY, USA;
Department of Medical Genetics, Henry Ford Hospital, Detroit, MI, USA;
Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, 800 Rose Street, Room MS 147, Lexington, KY, 40536, USA;
Medullary thyroid carcinoma; Calcitonin; CEA; Chromogranin A;
机译:甲状腺髓样癌患者组织与血清降钙素和癌胚抗原之间的差异。
机译:组合血清降钙素,癌胚抗原和神经元特异性烯醇酶预测髓质甲状腺癌的侧淋巴结转移
机译:甲状腺髓样癌外科细胞减少诱导血清降钙素和癌胚抗原倍增时间增加
机译:髓质甲状腺癌相关淀粉样蛋白由降钙素基因相关的肽II组成
机译:一种新的免疫测定法,用于定量血清中的新型癌症抗原,并对癌组织和培养细胞进行免疫染色,揭示了抗原性细胞的位置。
机译:结合血清降钙素癌胚抗原和神经元特异性烯醇化酶预测甲状腺髓样癌的侧向淋巴结转移
机译:癌症中的早期变化,但在降钙素水平中没有与细胞毒性化疗治疗的髓质甲状腺癌患者的无进展生存率相关